Alliance A071401: Phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations Meeting Abstract
| Authors: | Brastianos, P. K.; Dooley, K.; Geyer, S. M.; Gerstner, E. R.; Kaufmann, T. J.; Iafrate, A. J.; Milhem, M. M.; Welch, M. R.; Kaley, T. J.; Drappatz, J.; Chan, A.; Kumthekar, P.; Kamiya-Matsuoka, C.; Strowd, R. E.; Cohen, A. L.; Jaeckle, K. A.; Robell, L.; Santagata, S.; Barker, F. G.; Galanis, E. |
| Abstract Title: | Alliance A071401: Phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557400364 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.2001 |
| Notes: | Meeting Abstract: 2001 -- Source: Wos |
